EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods

Ziyu Kuang, Miao Kong, Ningzhe Yan, Xinyi Ma, Min Wu, Jie Li

Current Treatment Options in Oncology · 2024-05 · 25 (5) · 679-701

DOI: 10.1007/s11864-024-01203-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, online erschienen am 27.04.2024. Verfasst von Ziyu Kuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Genomics, Cardiovascular Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opinion statement Cardio-oncology is an emerging interdisciplinary field dedicated to the early detection and treatment of adverse cardiovascular events associated with anticancer treatment, and current clinical management of anticancer-treatment-related cardiovascular toxicity (CTR-CVT) remains limited by a lack of detailed phenotypic data. However, the promise of diagnosing CTR-CVT using deep phenotyping has emerged with the development of precision medicine, particularly the use of omics-based methodologies to discover sensitive biomarkers of the disease. In the future, combining information produced by a variety of omics methodologies could expand the clinical practice of cardio-oncology. In this review, we demonstrate how omics approaches can improve our comprehension of CTR-CVT deep phenotyping, discuss the positive and negative aspects of available omics approaches for CTR-CVT diagnosis, and outline how to integrate multiple sets of omics data into individualized monitoring and treatment. This will offer a reliable technical route for lowering cardiovascular morbidity and mortality in cancer patients and survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNeoplasmsGenomicsCardiovascular DiseasesCardiotoxicityHumansAntineoplastic AgentsBiomarkersMetabolomicsProteomicsMedical OncologyDisease ManagementDisease SusceptibilityCardio-Oncology

Stichwörter der Autor:innen

Cardio-oncologyCardiotoxicityOmicsPrecision medicine

Substanzen

Antineoplastic AgentsBiomarkers

Autor:innen und Institutionen

  • Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Graduate School, Beijing University of Chinese Medicine, Beijing, China.
  • Cardiovascular Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. wumin@gamyy.cn.
  • Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. qfm2020jieli@yeah.net.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kuang, Z., Kong, M., Yan, N., Ma, X., Wu, M., & Li, J. (2024). Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods. Current Treatment Options in Oncology, 25(5), 679-701. https://doi.org/10.1007/s11864-024-01203-6

Vancouver

Kuang Z, Kong M, Yan N, Ma X, Wu M, Li J. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods. Current Treatment Options in Oncology. 2024;25(5):679-701. doi:10.1007/s11864-024-01203-6

BibTeX
@article{Kuang2024,
  author = {Kuang, Ziyu and Kong, Miao and Yan, Ningzhe and Ma, Xinyi and Wu, Min and Li, Jie},
  title = {Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {679--701},
  doi = {10.1007/s11864-024-01203-6}
}
Kostenlos starten →